The Hidden Impact on Performance and Health When your body can't absorb B12, the consequences can be serious, creating a drag on your current performance and posing a long-term threat to your future health
Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
Not always 15-20% like the high-dose clinical trials, but 5-10% is common
All three patients remained alive without signs of disease recurrence over follow-up periods of three to four years post-surgery, which is favorable compared to previous survival rates for similar patient groups
This is particularly relevant because so many injuries (chronic Achilles tendinopathy, rotator cuff tears) occur in areas with inherently limited blood flow
Participant genotype data were imputed against a reference panel composed of data from the Haplotype Reference Consortium 34 and augmented with additional sequences to boost imputation performance (Supplementary Information)
.png)
